Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,765.00    -13.00 (-0.73%)
Bid:
1,768.00
Ask:
1,771.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Bondholders Presentation

30 Jul 2007 18:10

Derwent London PLC30 July 2007 30 July 2007 London Merchant Securities Limited (formerly London Merchant Securities plc) Annual presentation to holders of its £175m 6.50% secured bonds 2026 London Merchant Securities' annual presentation to its bond-holders will be heldat 10.00 a.m. on Monday 20 August 2007 at their offices, 25 Savile Row, London, W1S2ER. The meeting will be hosted by Chris Odom (Finance Director of DerwentLondon plc, which is the parent company of London Merchant Securities Limited). Could all those wishing to attend, please contact Tim Kite, the CompanySecretary. Two copies of the London Merchant Securities Limited Report & Accounts, as at31 December 2006, have been filed with the UK Listing Authority today and willbe available for inspection at the UK Listing Authority's Document ViewingFacility, which is situated at: Financial Services Authority25 The North Colonnade, Canary Wharf, London, E14 5HSTel: 020 7066 1000 For further information please contact: Tim Kite: 020 7659 3000 Nicholas Denman, JPMorgan Cazenove: 020 7155 4912 T J KiteCompany Secretary This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Aug 20257:00 amRNSInterim Results
5th Aug 20257:00 amRNSNew headlease agreed at 50 Baker Street W1
31st Jul 20254:45 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSDisposal of Francis House SW1 for £55.5m
25th Jul 20257:00 amRNSExtension of £450m Revolving Credit Facility
30th Jun 20254:45 pmRNSTotal Voting Rights
18th Jun 20257:00 amRNSAdobe lease extension and expansion
12th Jun 202511:00 amRNSRedemption of £175 million Convertible Bonds
30th May 20254:45 pmRNSTotal Voting Rights
29th May 202511:15 amRNSHolding(s) in Company
23rd May 20254:05 pmRNS£250m 7-year 5.25% bond issuance
16th May 202512:00 pmRNSResults of 2025 Annual General Meeting
8th May 20257:00 amRNSFirst Quarter Business Update
1st May 202510:00 amRNSAnnual Bondholder Meeting
30th Apr 20254:45 pmRNSTotal Voting Rights
15th Apr 202510:00 amRNSAnnual Financial Report
9th Apr 20253:00 pmRNSAdditional Listing
31st Mar 20254:45 pmRNSTotal Voting Rights
31st Mar 202510:00 amRNSNotice of Q1 2025 Business Update
26th Mar 20251:00 pmRNSDirector/PDMR Shareholding
20th Mar 20254:45 pmRNSBlock listing Interim Review
7th Mar 20252:00 pmRNSDirector/PDMR Shareholding
4th Mar 20255:15 pmRNSDirector/PDMR Shareholding
28th Feb 20254:45 pmRNSTotal Voting Rights
27th Feb 20257:00 amRNSResults for the Year Ended 31 December 2024
31st Jan 20254:45 pmRNSTotal Voting Rights
30th Jan 20255:35 pmRNSHolding(s) in Company
27th Jan 20251:30 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS25 Baker Street W1 offices fully pre-let
31st Dec 202412:45 pmRNSTotal Voting Rights
3rd Dec 20247:00 amRNSAcquisition
29th Nov 20244:45 pmRNSTotal Voting Rights
7th Nov 20247:00 amRNSTHIRD QUARTER BUSINESS UPDATE
5th Nov 202412:44 pmRNSHolding(s) in Company
31st Oct 20244:45 pmRNSTotal Voting Rights
23rd Oct 20245:30 pmRNSHolding(s) in Company
16th Oct 202410:30 amRNSDirectorate Change
30th Sep 20244:45 pmRNSTotal Voting Rights
20th Sep 20244:45 pmRNSBlock listing Interim Review
19th Sep 202411:00 amRNSDirector/PDMR Shareholding
17th Sep 202411:03 amRNSHolding(s) in Company
30th Aug 20244:45 pmRNSTotal Voting Rights
23rd Aug 202411:15 amRNSAdditional Listing
8th Aug 20247:00 amRNSHalf-Year Results
31st Jul 20244:45 pmRNSTotal Voting Rights
28th Jun 20244:45 pmRNSTotal Voting Rights
12th Jun 202411:00 amRNSHolding(s) in Company
10th Jun 20244:00 pmRNSDirector/PDMR Shareholding
31st May 20244:45 pmRNSTotal Voting Rights
31st May 202410:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.